Chemical formula: C₄₉H₆₈N₁₈O₉S₂ Molecular mass: 1,117.32 g/mol PubChem compound: 11993702
Setmelanotide is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Setmelanotide is indicated for the treatment of obesity and the control of hunger associated with loss-of-function biallelic pro-opiomelanocortin (POMC), including PCSK1, in adults and children 6 years of age and above.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Setmelanotide is indicated for the treatment of obesity and the control of hunger associated with deficiency or biallelic leptin receptor (LEPR) deficiency in adults and children 6 years of age and above.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Setmelanotide is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed Bardet-Biedl syndrome (BBS) in adults and children 6 years of age and above.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Setmelanotide is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
